提醒成功
微信/QQ登录
搜索
首页
| 产品规范 | |
|---|---|
| Type | In Vivo - Reseach Grade Antibody |
| Host | CHO cells |
| catalog# | B00034 |
| Application | Flow cytometry, animal model study |
| Aliases | Interleukin 12, IL-12, IL12, IL23, IL-23, p70, IL12B, IL-12p40, Interleukin 23 |
| Size/Concentration | 1mg/5mg/20mg |
| Isotype | Human IgG1 lambda |
| Storage | Store at 4°C 1 month, store at -20°C to -70°C 12 month. protected from prolonged exposure to light. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | Human IL-12 / IL-23 |
| Formulation | PBS, pH 7.4 |
Description |
|---|
What is Briakinumab Biosimilar research grade? Briakinumab is a human anti-IL-12 / IL-23 monoclonal antibody being developed for the treatment of a number of T-cell driven autoimmune diseases. It targets and neutralize interleukin-12 and interleukin-23, two proteins associated with inflammation, such as pro-inflammatory interleukins or tumor necrosis factor- alpha. Briakinumab represents a novel approach to treating psoriasis, Multiple Sclerosis, Crohn’s Disease and other autoimmune and inflammatory disorders. Briakinumab Biosimilar uses the same protein sequences as the therapeutic antibody briakinumab. |
Briakinumab Biosimilar, IL-12 / IL-23 Monoclonal Antibody B00034
规格：
- 1mg
- 5mg
- 20mg
数量：
-
+
说明书：
¥2275
-
分享
-
咨询
-
收藏
联系方式
CONTACT-
联系电话:
0731-88388785 -
公司邮箱:
sales@promab.cn -
公司地址:
湖南省长沙市高新开发区林语路239号顺畅产业园5楼
湖南省长沙市望城区普瑞大道8号出版科技园2号楼
官方微信
产品中心
Product技术服务
service客户留言
message